Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-22

Clinical Trial Update: the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of LDP in patients with bladder cancer, renal carcinoma, and advanced penile carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LDP

Snippet

Sponsor: Dragonboat Biopharmaceutical Company Limited | Conditions: Bladder Cancer, Renal Carcinoma | Phase 2 | Status: UNKNOWN